MHC class I epitope delivering polypeptides
US-12037367-B2 · Jul 16, 2024 · US
against neuromediator receptors, e.g. serotonin receptor, dopamine receptor
against neuromediator receptors, e.g. serotonin receptor, dopamine receptor · Cooperative Patent Classification (CPC)
Chemical and metallurgical processes, compounds, and materials.
Related technology areas
Mapped technology topics for this CPC code.
| Metric | Value |
|---|---|
| CPC code | C07K16/286 |
| Official title | {against neuromediator receptors, e.g. serotonin receptor, dopamine receptor} |
| Display label | against neuromediator receptors, e.g. serotonin receptor, dopamine receptor |
| Total patents | 194 |
Filing trend
Year-over-year patent counts classified under this CPC code.
Filing activity over the last five years is stable.
| Year | Patents |
|---|---|
| 2015 | 13 |
| 2016 | 12 |
| 2017 | 16 |
| 2018 | 14 |
| 2019 | 19 |
| 2020 | 16 |
| 2021 | 20 |
| 2022 | 18 |
| 2023 | 19 |
| 2024 | 22 |
| 2025 | 21 |
| 2026 | 4 |
Representative patents
Representative publications under this CPC code from precomputed stats, or recent filings when stats are unavailable.
Integral membrane protein display on poxvirus extracellular enveloped virions
US-2019112388-A1 · Apr 18, 2019 · US
Anti-sortilin antibodies and methods of use thereof
US-2019085084-A1 · Mar 21, 2019 · US
Multi-functional particles and methods of using the same
US-10232050-B1 · Mar 19, 2019 · US
Natriuretic peptide receptor as a biomarker for diagnosis and prognosis of cancer
US-10184942-B2 · Jan 22, 2019 · US
Novel antibody useful in neurological or neurodegenerative disorders
US-2018371082-A1 · Dec 27, 2018 · US
Agent, uses and methods for treatment
US-2018305455-A1 · Oct 25, 2018 · US
Anti-sortilin antibodies and methods of use thereof
US-10087255-B2 · Oct 2, 2018 · US
Anti-sortilin antibodies and methods of use thereof
US-2018265586-A1 · Sep 20, 2018 · US
Antibody useful in neurological or neurodegenerative disorders
US-10072077-B2 · Sep 11, 2018 · US
Antibodies which bind type i cannabinoid receptor/angiotensis ii receptor heteromers
US-2018250322-A1 · Sep 6, 2018 · US
Lrp4/corin dopamine-producing neuron precursor cell marker
US-9994816-B2 · Jun 12, 2018 · US
Methods and Pharmaceutical Compositions (NTSR1 Inhibitors) for the Treatment of Hepatocellular Carcinomas
US-2018134788-A1 · May 17, 2018 · US
Methods for detecting prostate cancer
US-2018119229-A1 · May 3, 2018 · US
Novel monoclonal antibody inhibitors targeting potassium channel kcnk9
US-2018092977-A1 · Apr 5, 2018 · US
Vaccines for preventing meningococcal infections
US-2018037612-A1 · Feb 8, 2018 · US
Human monoclonal antibodies against orexin receptor type 1
US-2018030135-A1 · Feb 1, 2018 · US
Human monoclonal antibodies against orexin receptor type 1
US-2018002421-A1 · Jan 4, 2018 · US
Antibodies which bind type I cannabinoid receptor/angiotensin II receptor heteromers and methods of use
US-9855290-B2 · Jan 2, 2018 · US
Diagnostic of Obliterative Arteriopathies
US-2017315140-A1 · Nov 2, 2017 · US
Frequently asked questions
Answers are generated from the same data shown on this page.
- What is CPC C07K16/286?
- CPC C07K16/286 is the Cooperative Patent Classification code for “against neuromediator receptors, e.g. serotonin receptor, dopamine receptor.”
- How many patents are filed under CPC C07K16/286 (against neuromediator receptors, e.g. serotonin receptor, dopamine receptor)?
- Our database includes 194 publications tagged with this CPC code.
- Is patent activity under CPC C07K16/286 growing?
- Publication counts under this code: 22 in 2024 vs 21 in 2025 (latest complete years).